|
|
|||
|
|
|||
![]() |
|||
|
|||
| Scientists map unstable region of chromosome 11 linked to tumors | |||||
|
By Kate Dalke August 30, 2002
|
Tumor cells often contain extra copies of a specific region of chromosome 11. Scientists have suspected that this region may be an area of genetic instability that promotes tumor growth and progression. The region is duplicated in half of all head and neck cancers as well as in breast, bladder and liver cancers. These extra copies are thought to increase the activity of certain genes, leading to the uncontrolled growth of tumor cells. The new map may help researchers study the link between smoking and cancer. The scientists pinpoint breaks in segments of the genome that promote extra copies of DNAa process known as 'gene amplification.' These breakpoints may be related to exposure to cigarette smoke, a leading cause of oral cancer. "We suspect that one of the ways in which smoking-related cancers develop is by chromosome breakage and rearrangement," says Susanne M. Gollin, who led the study at the University of Pittsburgh Graduate School of Public Health. "Smoking really shatters chromosomes," Gollin adds. The study reports that over 60 percent of the examined oral cancer cells had extra copies of the region. Researchers studied 30 cell lines from the tumors of oral cancer patients using a new mapping technique called quantitative microsatellite analysis (QuMA). In one of the tumors, the team found nearly 80 copies of the region compared with the two copies typically found in normal cells. Genes in these copied regions are thought to give cells a "proliferative advantage" that leads to tumor development, the authors report in the study published in Proceedings of the National Academy of Sciences. The core region of chromosomal band 11q13 contains at least nine different genes. The newly identified TAOS1 gene along with the gene CCND1which has also been found to be overexpressed in breast cancercould be "the driving force" in gene amplification, the scientists say. Gollin plans to further investigate the role of gene amplification in cancer cells. She says the newly discovered gene could become a reliable indicator for diagnosing the progression of tumors and a patient's response to therapy.
. . . |
||||